Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 9/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | HPGDS | O60760 | 2/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25458684 | 0.86 | MCL1 (0.38) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL23900202 | 0.83 | MCL1 (0.31) | MCL1ADORA3ADORA2BADORA1 | |
| SCHEMBL20936376 | 0.80 | MCL1 (0.41) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL19368575 | 0.78 | MCL1 (0.41) | MCL1DHODHESR1ESR2ADORA3 | |
| SCHEMBL17932830 | 0.78 | CYP19A1 (0.49) | DHODHESR1ESR2HPGDSMEN1 | |
| SCHEMBL24627008 | 0.78 | KDM4E (0.34) | ADORA3ADORA2BADORA1CYP19A1 | |
| SCHEMBL22114508 | 0.75 | KAT6A (0.35) | HPGDSGRM5 | |
| SCHEMBL19074777 | 0.75 | GRM5 (0.37) | MCL1DHODHESR1ESR2GRM5 | |
| SCHEMBL23809574 | 0.74 | HPGDS (0.53) | HPGDSCHEK2 | |
| SCHEMBL24589096 | 0.74 | MCL1 (0.37) | MCL1DHODHADORA3ADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-20210104673-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2021-04-08 | — | — | US | disclosed |
| US-20200295279-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-09-17 | — | — | US | disclosed |
| US-20200190113-A1 | CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DISPLAY APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190113-A1 | CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DISPLAY APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | OCIAD1, CRY1, OCIAD2 | MCL1 3471/4885DHODH 387/4885ESR1 493/4885 |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | MCL1 2616/4885DHODH 4144/4885ESR1 43/4885 |
| US-20210104673-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | C1S, CCNT1, C9 | MCL1 2616/4885DHODH 4144/4885ESR1 43/4885 |
| US-20200295279-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | ORC3, ZC3HAV1L, ICMT | MCL1 2013/4885DHODH 529/4885ESR1 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.